Proton Partners International Recognised in Global Proton Beam Therapy Study

Two members of Proton Partners International staff have been ranked amongst the ‘high performers’ in an international proton planning study carried out by the Particle Therapy Co-Operative Group (PTCOG) and the Mayo Clinic.

Jamil Lambert, a physicist, and Karen O’Neill, a dosimetrist, took part in the international, multi-institutional quality improvement project in which the PTCOG paediatric group invited experts to submit a treatment plan using proton beam therapy on a paediatric patient.

The goal of the study was to learn the best proton beam therapy techniques and share the findings with the wider community. The patient’s CT and all of the structures were provided, and then the individual centres used their own beam models and treatment techniques to create a treatment plan.

Plans were assessed depending on whether it met the treatment goals. High scoring plans, like those submitted by Jamil and Karen, are those which had a good dose coverage of the target, as well as delivering a low dose to all of the organs at risk.

The results were first presented at the 2017 International PTCOG meeting in May 2017 in Japan.

Mike Moran, chief executive officer of Proton Partners International, said: “We have recruited some of the leading cancer specialists in the country and it’s great to see that their talents have been recognised in this study.

“Two important words for us are ‘innovation’ and ‘collaboration’ – both of which are central to our company ethos. By participating in this global study, Jamil and Karen have demonstrated that they are playing their part in the wider research effort, and sharing data is a key part of that. They have also shown that it’s essential we work collaboratively to innovate, in proton beam therapy and in other areas, so that we can learn from each other and build a greater level of expertise together.”

The results of the study can be accessed here.